Edge Restenosis with Everolimus Eluting Stents: a few Predictors

Edge Restenosis with Everolimus Eluting StentsStent edge restenosis continues to be a weakness of drug eluting stents (DES). The aim of this study was to determine its predictors using optical coherence tomography (OCT).

 

The study retrospectively analyzed 319 patients receiving OCT immediately after everolimus eluting stent implantation (EES) looking into the immediate outcome, and follow up angiography at 9 and 12 months.

 

Binary angiographic stent edge restenosis was 10%. OCT more often showed lipidic plaque in patients with stent edge restenosis vs. those without it. (61% vs. 20%; p<0.001), as well as smaller minimal lumen area (4.13±2.61 vs. 5.58±2.46 mm2; p=0.001). Multivariable analysis confirmed these two variables are significant predictors of stent edge restenosis.

 

A lipidic arc of 185° (sensitivity: 71%; specificity: 72%; area under the curve: 0.761) and minimal lumen area of 4.10 mm2 (sensitivity: 67%; specificity: 77%; area under the curve: 0.787) were the ideal cutoff values to predict stent edge restenosis.

 

These results do not come as a surprise since it is well known that plaque in the distal or proximal stent edges and stent underexpansion are restenosis predictors.

 

Conclusion

OCT provides decisive information on optimal stent diameter and expansion to select the right stent length, which in turn will allow us to cover the whole plaque.

 

Original Title: Optical Coherence Tomography Predictors for Edge Restenosis after Everolimus-Eluting Stent Implantation.

Reference: Ino Y et al. Circ Cardiovasc Interv. 2016 Oct; 9(10).


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...